Department of Pharmaceutical Technology, Medical University of Bialystok, Białystok, Poland.
Department of Pharmaceutical Technology, Medical University of Bialystok, Białystok, Poland.
Pharmacol Rep. 2019 Feb;71(1):156-166. doi: 10.1016/j.pharep.2018.10.008. Epub 2018 Oct 11.
Skin application of pharmaceutical products is one of the methods used for drug administration. The problem of limited drug penetration via topical application makes searching for safe drug carriers that will provide an expected therapeutic effect of utmost importance. Research into safe drug carriers began with liposome structures, paving the way for work with nanocarriers, which currently play a large role as drug vehicles. Nanostructured lipid carriers (NLC) consist of blended solid and liquid lipids (oils) dispersed in an aqueous solution containing a surfactant. These carriers have many advantages: good biocompatibility, low cytotoxicity, high drug content; they enhance a drug's stability and have many possibilities of application (oral, intravenous, pulmonary, ocular, dermal). The following article presents properties, methods of preparation and tests to assess the quality and toxicity of NLC. This analysis indicates the possibility of using NLC for dermal and transdermal drug application.
皮肤给药是药物给药的方法之一。局部应用时药物渗透有限的问题使得寻找安全的药物载体以提供预期的治疗效果变得至关重要。安全药物载体的研究始于脂质体结构,为纳米载体的研究铺平了道路,纳米载体目前在作为药物载体方面发挥着重要作用。纳米结构脂质载体(NLC)由混合的固体和液体脂质(油)分散在含有表面活性剂的水溶液中组成。这些载体具有许多优点:良好的生物相容性、低细胞毒性、高药物含量;它们可以提高药物的稳定性,并且具有多种应用可能性(口服、静脉内、肺部、眼部、皮肤)。本文介绍了 NLC 的性质、制备方法和质量评估测试毒性。该分析表明,NLC 可用于皮肤和经皮药物应用。